Welcome to our dedicated page for Lam Research SEC filings (Ticker: LRCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lam Research Corp. filings document regulatory disclosures for a semiconductor wafer fabrication equipment company. Its Form 8-K reports include operating results and financial-condition updates, material-event disclosures, exhibits for quarterly earnings releases, governance matters, capital-structure items, and changes affecting security-holder rights.
Lam Research proxy and related filings cover annual meeting proposals, director elections, executive compensation advisory votes, stock incentive plan approvals, auditor ratification, charter amendments, stockholder proposals, and changes in the company’s independent registered public accounting firm.
Lam Research Corp director Eric Brandt reported open-market sales of 54,500 shares of common stock on June 12, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 6, 2026, at prices ranging from $355.39 to $373.36 per share. Following these transactions, he directly owns 198,905 shares, including shares subject to unvested restricted stock units.
LAM RESEARCH CORP director Eric Brandt reported a series of open‑market sales of company common stock. On June 11, 2026, he sold a total of 54,500 shares in multiple transactions under a pre‑arranged Rule 10b5‑1 trading plan adopted on February 6, 2026.
The reported weighted‑average sale prices for these trades ranged from about $337 to $364 per share. Following the transactions, Brandt directly owned 199,205 shares of Lam Research common stock, and this amount includes shares subject to unvested restricted stock units.
LRCX notice on Form 144 reports an intended sale of 54,500 shares of Common Stock, with the filing dated 06/12/2026 and Nasdaq as the exchange. The filing lists Fidelity Brokerage Services LLC with an address and shows the shares originate from two restricted‑stock vesting events dated 01/31/2014 (26,250 shares) and 10/31/2014 (28,250 shares).
Company: The filing reports proposed sales of 54,500 shares of Common Stock under Rule 144. The notice names Fidelity Brokerage Services LLC and lists an aggregate amount of $19,118,337.80 alongside a date of 06/11/2026. The excerpt also lists prior restricted stock vesting events of 29,480, 12,970, and 12,050 shares dated 01/25/2013, 11/04/2013, and 01/31/2014, respectively.
Neil J. Fernandes, Senior Vice President of LAM RESEARCH CORP, sold 7,659 shares of common stock at $309.60 per share in an open-market transaction pursuant to a Rule 10b5-1 trading plan. He now holds 58,470 shares directly and 1,015.395 shares indirectly through a 401(k) plan.
LRCX: Notice of proposed resale of Common Stock under Rule 144 by Fidelity Brokerage Services LLC and a reporting person. The filing lists 7,659 shares of Common Stock associated with a restricted stock vesting event dated 03/01/2025. It also reports prior sales of 18,170 shares on 05/01/2026 for $4,635,893.80. The form identifies the broker-dealer and lists an as-of date of 06/01/2026.
LRCX submitted a Form 144 reporting a proposed sale of 59,490 shares on 05/14/2026. The filing lists three option-related lots of 21,220, 28,140 and 10,130 shares tied to options granted on 03/01/2024, 03/01/2023 and 03/01/2022cash transactions through Fidelity Brokerage Services LLC on NASDAQ.
LAM Research Senior Vice President Neil J. Fernandes reported an open-market sale of 18,170 shares of LAM Research common stock at $255.14 per share. The transaction is coded as an open-market sale and was carried out under a Rule 10b5-1 trading plan adopted on November 17, 2025.
Following this sale, Fernandes directly holds 66,129 shares of LAM Research common stock. He also has an indirect holding of 1,015.399 shares through a 401(k) plan, and this amount includes shares subject to unvested restricted stock units.
LRCX notice of a proposed brokered sale: 18,170 shares of Common Stock are listed for sale through Fidelity Brokerage Services LLC with an aggregate value of $4,635,893.80, and the filing shows 05/01/2026 and NASDAQ.
The filing also lists underlying restricted stock vesting entries of 7,500 shares (03/01/2022) and 10,670 shares (03/01/2024) that relate to compensation awards; the notice names the broker as the selling channel.
Vanguard Capital Management reported beneficial ownership of 93,575,293 shares of Lam Research Corp common stock, representing 7.49% of the class. The filing shows sole dispositive power over those shares and sole voting power of 12,419,549 shares. The filing lists Vanguard affiliates that exercise voting or dispositive power on behalf of funds and clients.